notreload
@thudderwicks
Followers
1,213
Following
14
Media
630
Statuses
58,165
notreload is an Ai-based web service that helps users automating public web content monitoring for investing and trading purposes. Not advice.
Wall Street
Joined June 2021
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Gojo
• 135557 Tweets
#jjk260
• 134924 Tweets
#ڈر_گئے_خان_کی_جھلک_سے
• 112919 Tweets
#wewantimrankhanlive
• 81377 Tweets
共同親権
• 60342 Tweets
Sukuna
• 57695 Tweets
Colin
• 45853 Tweets
マイクラ
• 38393 Tweets
サマソニ
• 34468 Tweets
高橋一生
• 33792 Tweets
OPENING STORE WITH SAROCHA
• 33160 Tweets
Gege
• 31583 Tweets
#OUROCKSTAR_MARK_200
• 27721 Tweets
#GoldenGooseFREEN
• 27158 Tweets
都知事選
• 27036 Tweets
#BRIDGERTON
• 26305 Tweets
MARK 200 OUT NOW
• 24756 Tweets
石丸市長
• 15974 Tweets
多極分散
• 14386 Tweets
出馬表明
• 14127 Tweets
岸辺露伴
• 13154 Tweets
スニーク
• 12774 Tweets
ビシエド
• 12336 Tweets
#SunilChhetri
• 11998 Tweets
Happy Retirement Legend
• 11676 Tweets
ミャクミャク様
• 11352 Tweets
Favourite IPL
• 10592 Tweets
安芸高田市
• 10400 Tweets
ゲンスルー
• 10051 Tweets
Pinned Tweet
We're on Telegram, follow us for 24/7 news alerts👇
1
1
2
$MANU
1
31
47
$LCID was rising 7.9% after it reached a supply agreement with Aston Martin. Under the agreement, Lucid will supply Aston Martin with “industry-leading electric-vehicle technologies.”
2
1
22
$RVVTF provides update on Phase 3 trial for bucillamine in COVID-19
1
4
21
$HGEN lenzilumab reduces cytokine release syndrome in published study
1
0
22
Clinical trial will evaluate $CTMX CX-801 as monotherapy and in combination with $MRK KEYTRUDA in patients with advanced metastatic solid tumors including melanoma, renal cell carcinoma and head and neck squamous cell carcinoma.
2
0
6
“The Qatari offer is currently viewed by the Glazers more favorably than a bid from British billionaire Jim Ratcliffe. Members of the Glazer family, which own minority stakes in $MANU, would be cashing out as part of the proposed deal,”
@Reuters
reported
1
8
20
$BABA raises share repurchase authorization by $25B
2
1
18
$ALPP Quality Circuit Assembly receives $4.8M in orders
0
5
18
$OCGN said the FDA has granted RMAT designation to Ocugen’s investigational product OCU400 for the treatment of retinitis pigmentosa (RP) associated with RHO mutations.
1
6
18
$BB reported Q4 adj. EPS of $0.03, $0.07 better than the analyst estimate of ($0.04); Total company revenue was $173M, consensus $150.47M; IoT revenue was an “all-time quarterly record” $66M, up 25% y/y; Cybersecurity revenue was $92M, up 5% y/y.
0
3
14
$RVVTF disclosed the submission of a request to the FDA seeking the agency’s agreement for potentially new main goals for its Phase 3 clinical trial for Bucillamine in mild to moderate COVID-19.
1
4
13
$NILE unit awarded contract from leader in Distributed Access Architecture
0
2
11
Citi opens “positive catalyst watch” on $ARDX into FDA decision
1
3
12
$ALPP ElecJet to build solid-state battery prototype production line in San Jose, CA
0
5
11
$MQ said that it had signed a four year extension with $SQ to continue powering its popular Cash App card product.
1
1
10
$HGEN announces peer-reviewed publication on lenzilumab
0
2
11
$HMBL selected to pilot digital wallet program with County of Santa Cruz, CA
0
0
10
$SMCI reported Q3 adj. EPS of $6.65, $0.85 better than the analyst estimate of $5.80; Net sales of $3.85B, versus $3.66B in the second quarter of fiscal year 2024, and $1.28B in the same quarter of last year, consensus $3.99B.
2
4
11
$WNRS VegasWinners receives $GOOGL approval for sports betting campaigns in Indiana
0
5
5
$VTGN initiated with an Outperform at William Blair, shares rose 2.8%
2
3
10
$ALPP Quality Circuit Assembly announces plans for CA facility
1
5
10
$MULN announces addition of Detroit EV technology team
1
1
10
"The revised goals will provide FDA with more meaningful study endpoints to consider for a potential Emergency Use Authorization (EUA) for the therapy," $RVVTF said.
1
2
10
$BB said it has joined hands with $AMD to boost their capabilities in robotics-focused hardware with a platform to deliver “enhanced performance, reliability, and scalability for robotic systems in industrial and healthcare sectors.”
0
3
10
$BLNK reports Q3 adj. EPS (16c), consensus (47c)
1
8
10
$PBR approves shareholder remuneration of R$1.893577 per share
0
3
9
$RVVTF received positive comments from the FDA to determine potential new clinical endpoints to support Emergency Use Authorization.
1
2
10
$AUPH enters patent settlement pact with Sun Pharmaceuticals
2
1
8
$MULN eliminates $17.5M in company debt
1
0
8
$PLCKF nabs Plurilock DEFEND order with California-based pension fund
0
0
2
@greg16676935420
“Money itself isn’t lost or made, its simply transferred from one perception to another.” Gordon Gekko, Wall Street, 1987
1
1
9
$LLY board has announced a 15% increase in its quarterly dividend and declared a dividend for the first quarter of 2024 of $1.30 per share on outstanding common stock.
1
4
9
$APDN "If the test is validated by ADCL, a validation package will be submitted to New York State Department of Health (NYSDOH) for approval. If approved, the test will be used to power ADCL’s monkeypox testing services."
1
4
9
$MULN Transaction valued at approximately $200M; deliveries commencing First Quarter 2023.
1
3
8
$BNGO issued US patent for analysis of small nucleic acid fragments
0
1
8
$BABA reports Q2 adj. EPS $2.14, consensus $2.11
1
3
8
$RVVTF plans to obtain the FDA agreement on the new endpoints in June 2022.
0
1
8
$AVTX said it has acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio.
1
1
8
$INBS said it has received National Association of Testing Authorities (NATA) accreditation for its Intelligent Fingerprinting Drug Screening Solution.
0
3
7
$RGBP +36% after patent filing
0
0
7
$PLTR awarded $36M contract by the Army
0
2
8
Raymond James upgrades $ALTM from Outperform to Strong Buy and maintains $9 price target.
0
2
7
$PTCT expects the European Commission to ratify the marketing authorization for Upstaza under exceptional circumstances in approximately two months.
0
0
7
$IOVA disclosed that its director Wayne Rothbaum bought 1M shares of common stock on May 31st in a total transaction size of $6.6M.
2
2
7
$PLTR shares dropped 8.4%. William Blair analysts noted that "customer concerns" over data ownership could limit the analytics-software company’s future gains.
2
0
7
$FUBO ended the quarter with 1.618M paid subscribers, up 12% y/y, and $402M in total revenue, up 29% y/y, consensus $397.8M
1
1
6
Stifel says $SIVB fallout “appears limited” across firm's biotech coverage - $BEAM, $EDIT, $FOLD, $FULC, $NTLA, $RARE, $RCKT, $PRQR.
1
2
7
“Soquelitinib demonstrated durable anti-tumor activity, evidenced by progression free survival, duration of response and overall survival rates that exceed current standard of care therapies for patients with relapsed PTCL,” $CRVS
1
0
7
$ATNM said that the University of Texas Southwestern Medical Center will lead a clinical trial studying Actinium's Iomab-ACT, a targeted radiotherapy conditioning agent prior to patients receiving an FDA approved commercial CAR T-cell therapy.
1
1
7
$NVAX reported Q4 EPS of ($1.44), $0.99 worse than the analyst estimate of ($0.45); Revenue of $291M, consensus $321.97M.
2
1
7
Oppenheimer starts $XERS at Outperform, “successful commercial execution will continue to drive top-line growth.”
1
1
7
$PLPL announced that the U.S. SEC canceled civil penalties and interest totaling approximately $200,000 related to the Commission's 2018 action against the Company and its former Chairman of the Board and CEO, Mr. Roger Duffield.
0
0
7
“The 44% reduction in the $IONS 80 mg cohort [50 mg cohort was not statistically significant at six months vs. placebo] did not compare favorably to competitors, notably $ARWR Plozasiran, which showed a roughly 90% reduction in a Phase 1 study,” said Bernstein.
1
1
7
$MULN reports $99M in cash on hand as of August 8
1
2
7
Small Pharma is a U.K.-based biotechnology company focused on short-duration psychedelic therapies for mental health conditions. $CYBN shares rose 6.3%
1
2
6
$NKLA shares soared 21% after the electric heavy-duty truck start-up announced the appointment of Mary Chan, a managing partner at VectoIQ who helped with the public launch of $NKLA, as its COO, effective Oct. 9.
0
1
6
$IDEX enters energy charging solutions deal with Coast Counties Peterbilt
1
1
6
$MULN has eliminated $17.5M in company debt and reduced its overall indebtedness from more than $30M last year to an estimated $11M currently.
1
0
6
$BA deliveries reach highest monthly level since March 2019
0
2
6
HC Wainwright & Co. reiterates $SGMO with a Buy and raises the price target from $3 to $5.
0
0
6
$FSR shares surged 10.6% in premarket trading, after the electric vehicle maker said it plans to announce in January a plan to accelerate sales and deliveries.
1
2
5
“Phase 2 interim results for CYB003 demonstrating a rapid, robust and statistically significant reduction in symptoms of depression three weeks following a single 12mg dose compared to placebo,” $CYBN
1
2
6
UBS initiates coverage on $ASTS with a Buy rating and announces price target of $7.
0
1
6
$CEIX +9.3%, $BTU +9%, $ARCH +6.27%, $NC +5.6%, $AMR +6.44%, $ARLP +5.5%, $METC +4.16%, $HCC +2.43% Asia coal prices hit record on hot global competition for fuel
0
1
6
David Ellison has made a “preliminary offer” to acquire National Amusements, the holding company of the Redstone family, as a way to take control of $PARA, per
@business
1
1
6
$EVGO teases partnership with $MULN in tweet.
We’re looking forward to seeing the Mullen FIVE hit the streets in 2024. With an estimated range of 325 miles, the FIVE can charge 0-80% in 21 minutes - and we've got the network to keep future Mullen drivers going!
85
175
670
1
2
4
$HGEN Phase 3 SHIELD study utilizing lenzilumab to prophylactically neutralize GM-CSF in CAR-T to begin 1H22.
1
1
6
$AISP said it has been awarded a large contract to an agency within the Department of Justice (DOJ) for the company’s Acropolis Enterprise Sensor Management video and data management platform supporting emerging public safety and investigative requirements
0
2
6
$MULN announces new hires to join facilities in California, Mississippi
0
0
6
$BFLY announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.
0
2
6
$LEXX enters DehydraTECH fee agreement with Altria Client Services
1
1
5
$CLOV reaffirms FY22 revenue view $3.0B-$3.4B, consensus $3.24B.
1
0
6
$PSNY said it has secured $950M in external funding. “The company is making strong progress on its strengthened business plan and achieving its 2025 targets,” announced Polestar
1
0
5
$AMAT is under U.S. criminal investigation for potentially evading export restrictions on China's top chipmaker SMIC, per
@Reuters
3
0
5
$XELA wins $13.2M contract for bills and payment
1
2
5
$TLRY, $HEXO "Canada’s top two cannabis market leaders to join forces, strengthening operations and unlocking up to $80M of shared cost synergies."
0
0
4
$PHIO said the U.S. Patent and Trademark Office (USPTO) has granted patent application for two of its INTASYL Compounds, RXI-185 and RXI-231.
1
1
5
AgPlenus, a subsidiary of $EVGN, announced the signing of a licensing & collaboration agreement with Bayer.
1
1
5
$GFAI surpasses 4,800 robot deployments worldwide
1
0
5